Skip to main content

Advertisement

Table 3 Tumour and treatment characteristics for patients with local failure (n = 9)

From: Spinal radiosurgery - efficacy and safety after prior conventional radiotherapy

No. Tumour type Location Volume (cc) Prescription Dose (Gy) SRS Isodose (%) SRS Time (months) RTX to SRS Prior RTX Dose nBED Gy 2/2
1 RCC T11 93.3 16 65 21.7 42,8
2 RCC L3 134.2 19 55 8.8 40
3 Chordoma L2 39.7 22 65 12.4 40
4 Prostate T11 89.8 18 65 2.8 45
5 Melanoma C7 17.7 17 65 4.3 33.6
6 Sarcoma L4 56.3 20 70 2 44
7 Breast L3 37.6 20 70 28.8 42.8
8 MPNST T1 26.8 14.5 70 5.8 42.8
9 RCC T9 49.9 22 70 13.9 42.8
  Median - 49.9 19 65 8.8 42.8
  Mean - 60.6 18.8 66 11.2 41.6
  Range - 18-134 14.5-22 55-70 2-28.8 33.6-45
  1. Abbreviations: SRS = spinal radiosurgery; RTX = conventional radiotherapy; RCC = renal cell carcinoma; MPNST = malignant peripheral nerve sheath tumour